Introduction
============

Arthritis is a term used to describe inflammation of the joints. Osteoarthritis (OA), is one of the most common diseases from middle age onwards ([@R1]). In osteoarthritis, cartilage undergoes biochemical and biomechanical changes either as a cause or effect of the disease ([@R2]). Globally, there are 20.7 million or about %12.1 suffering from this disease ([@R3]). Although cartilage has a relatively simple structure compared to other tissues, cartilaginous injuries cannot be cured because chondrocytes cannot proliferate in the body. The limited cartilage blood supply is thought to be responsible for the lack of post injury repair ([@R4]). Several procedures, such as microfracture (MFX), osteochondral autograft transfer system, and mosaicplasty are devised to relieve pain, restore function, and delay or halt the progression of focal cartilaginous defects. However, none of thecurrent treatments are definitive, because pain and limitation of joint movement are not completely cured, but are alleviated. In contrast to mentioned treatments, in the last two decades, tissue engineering including autologous chondrocyte implantation (ACI) was presented as a cell therapeutic technique which proved to be a decisive treatment for traumatic acute osteoarthritis and osteoarthritis desiccant. However, treatment of chronic degenerative osteoarthritis, is still problematic and is not cured even with ACI, because of limitations of cell source and also harvested cells in *in vitro* proliferation methods ([@R5]--[@R7]). The introduction of stem cells in therapeutic domains has opened a new window to chondrocyte transplantation, because it was able to remove limitations in these cell therapy techniques ([@R8]). Therefore, current research in this field focuses on producing chondrocytes from stem cell source ([@R9]), by differentiation of ADSC (chondrogenesis), which also needs some chemical (e.g. Transforming Growth Factor β) or physical inducers (e.g. electric field or ultrasonic wave). Adipose-derived stem cells are an attractive source of cells for tissue differentiation and clinical applications due to easy access, large amounts of adipose tissue in adults, and convenience as a source for cell proliferation ([@R10], [@R11]). However, many researchers tested many chemical and physical inducers and found that the harvested cartilage tissues are not the same as normal hyaline cartilage, due to having much type I & X collagen and not enough type II collagen ([@R12]). Therefore, researchers continue investigating production of a cartilage tissue with better quality. In this study, we use high frequency electric field as a physical inducer for chondrogenesis induction in adipose-derived stem cells, in order to create proper cartilage tissue with more type II collagen and less type I & X collagen.

Materials and Methods
=====================

Isolation and proliferation of adipose derived stem cells
---------------------------------------------------------

Human ADSCs were extracted from subcutaneous abdominal adipose tissue taken from women who underwent caesarean section (30--40 years). Adipose tissue was mechanically minced and washed with PBS (Sigma) and was then digested with collagenase IA (1 mg/1g). The cell solution was centrifuged at 1500 rpm for 10 min. The pellet was resuspended in culture medium containing DMEM-LG supplemented with 10% FBS, 1% penicillin and streptomycin (Gibco) and was then cultured and kept at 37°C, 5% CO~2~ conditions. In order to examine the morphology of the cells, photographs were taken by an invert microscope, at different time intervals ([@R13]).

Flow cytometry
--------------

The percentage of cell markers was quantified by flow cytometry. Cells were released with trypsin-EDTA, rinsed, and suspended in PBS. Cell suspension was split into aliquots (100 µl), an unstained group, 5 µl mouse antibody IgG 1,2 (negative control), 5 µl mouse anti-human monoclonal CD105(Abcam) and mouse anti-human monoclonal CD 44 (DAKO Cytomation), 5 µl mouse anti-human monoclonal CD 14,45 (IQ Product). Next, samples were incubated for 30 min in the dark at 4°C. The cells were washed and centrifuged at 1500 rpm for 10 min. The supernatant was removed, the labeled cell pellet was resuspended in 200 µl PBS, and the FACS analysis was done ([@R14]).

*in vitro* chondrogenic differentiation
---------------------------------------

### Chondrogenic differentiation media contained

DMEM-HG (High Glucose) (Gibco), penicillin and streptomycin 1% (Gibco), dexamethasone 10^-7^M (Sigma), ascorbate-2-phosphate 50 µg/ml(Sigma), bovine serum albumin 0.5 mg/ml (Sigma), linoleic acid 5 µg/ml (Sigma), 10 mg/ml insulin, 5.5 mg/l transferring, 5 µg/l selenium (ITS) (Sigma), with and without adding transforming growth factor-β 3 (TGFβ3 ) 10 ng/ml (Sigma) ([@R14]). In this study, a 3D micromass culture system of ADSCs was used. Briefly, for passage two, the cells were trypsinized and resuspended in growth media at a density of 250,000 cells in 12.5 µl medium. The microliter droplets were seeded in a 24-well plate and allowed to form cell aggregates and were incubated at 37°C for two and a half hrs. Chondrogenic differentiation media was carefully added around the cell aggregates after this time ([@R15]).

Capacitively coupled electrical stimulation
-------------------------------------------

Capacitively electric fields (20 mv/cm, 60 KHz) were delivered to the cultured cells. The electric field was designed by the microcontroller (ATMEGA16). In this way, first pulse wave was generated by the microcontroller. Then, the electric field intensity was amplified by the push-pull electronic circuit and applied to the cells which were cultured in modified cooper tissue culture plate ([@R16]).

Experimental design
-------------------

The study setup included four groups; a control group consisting of ADSCs in chondrogenic media without TGF-β, and 3 experimental groups including a subgroup of cells in chondrogenic media with TGF-β, one subgroup of cells in chondrogenic media without TGF-β and applied EF stimulation, and another one of cells in chondrogenic media with TGF-β and applied EF stimulation. The applied signal was a pulsed wave applied for 20 min daily for 7 days.

MTT assay (3,4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium-bromide)
------------------------------------------------------------------------

The viability of ADSCs with EF exposure was assessed by the MTT assay on 7^th^ day. At first, the medium of each well was removed, rinsed with PBS, and replaced with 400 µl serum free medium and a 40 µl MTT solution. Next, it was incubated at 37°C, 5% CO~2~ for 4 hr. The medium was discarded and 400 µl DMSO (Sigma) was added to each well, and was incubated in dark for 2 hr. Next, 100 µl of the solution was transferred to a 96-well plate and absorbance of each well was read at 570 nm with ELISA reader (Hiperion MPR4). The assays were performed in triplicate ([@R17], [@R18]).

Enzyme-linked immunosorbent assay
---------------------------------

The amount of aggrecan (AGC) was quantified in supernatant culture media on the 7^th^ day, according to protocol of Human Aggrecan Direct ELSA kit (Invitrogen). Briefly, supernatant media as antigens were added to ELISA plate and AGC molecules bound to coated antibodies. Next, the enzyme conjugated antibodies were added which linked to antigens and formed antigen-antibody sandwiches. Finally, enzyme\`s substrate was added and the absorbance of the mixture was measured at a wavelength of 450 nm by spectrophotometer ([@R19]).

RNA isolation and real-time polymerase chain reaction (PCR)
-----------------------------------------------------------

Real-time quantitative RT-PCR was performed to quantitatively estimate the mRNA expression of type I, II, X collagens, and SOX~9~ genes in ADSCs at different groups. Total RNA was isolated by RNeasy mini kit (Qiagen), treated by RNase-free DNase set (Qiagen) to eliminate the genomic DNA. The RNA concentration was determined using a biophotometer (Eppendorf). Total RNA (100 ng) was reverse-transcribed to cDNA by using RevertAid^™^ First Strand cDNA Synthesis Kit (Fermentas) according to the manufacturer's instructions. The Maxima SYBR Green Rox qPCR master mix kit (Fermentas) was used for real-time RT-PCR. Primer sequences are shown in Table [1](#T1){ref-type="table"}. Real-time PCR reactions were performed by using the Comparative Ct (∆∆Ct) method. The relative expression level of genes was computed by calculating the ratio of the amount of genes to that of endogenous control (GAPDH). Melting curve to determine the melting temperature of specific amplification was produced. These experiments were carried out in triplicate and were independently repeated at least 3 times ([@R20]).

Statistical tests
-----------------

The Kolmogorov-Smirnov test was used for assessing normal distribution of variables and ANOVA (one-way analysis of variance) with the LSD *post hoc* test for the comparison of results in different groups.

Results
=======

Morphology of ADSCs after EF exposure
-------------------------------------

The morphology of EF exposure and control groups were almost the same and all of them were uniform and spindle-shaped for the duration of the 7 days.

Micromass formation
-------------------

Micromass droplets aggregate spherically in 24 hr in all groups; while cell droplets in EF exposed groups condense and the mass form appears in day 3, but in control group this process is performed on the 4^th^ day.

Flow cytometry
--------------

This analysis confirms stemness of the isolated cells. The results show that they are negative for CD 14 and 45(0.14%) but expressed CD 44 and CD 90 (89.69%) at high level.

MTT
---

Followed by treatment with MTT solution, the dark blue formazan crystals are seen in ADSCs which indicates their metabolic activity. However, applying EF improves viability and proliferation of ADSCs, but the comparison of results shows that they don\'t have significant differences (*P*\>0.05). These results show that EF is not fatal to the cells during the 7 days.

ELISA
-----

The general results show that the amount of produced AGC from cells exposed to EF are more than that of control group, on the 7^th^ day (*P*\<0.05). The addition of TGFβ3 to chondrogenic media leads to enhanced AGC production compared to the control group, but the difference is not significant (*P*\>0.05). On the other hand, the group with a growth factor and exposed to EF produced more AGC than control group (*P*\<0.001) and other groups (*P*\<0.05). Findings indicate, although the presence of TGFβ3 can increase AGC production, EF is more effective (*P*\<0.05).

Real-time PCR
-------------

The results of real-time PCR indicate that type II collagen and SOX~9~ gene expression in the group having TGFβ and exposed to EF are significantly higher (*P*\<0.001) than the control group and other groups. Expression of type II collagen and SOX~9~ genes in the group with applied EF only, is more than in the group affected just by TGFβ, but they are not significantly different (*P*\>0.05).

The results of real-time PCR show that type X (as hypertrophic marker) and I (as fibro cartilage marker) collagen gene expression in the group affected by EF only, is significantly lower than control group (*P*\<0.001). Although expression of type I and X collagen genes in this group is lower than the group just affected by TGFβ and the group affected by both TGFβ and exposure to EF, differences are not significant (*P*\>0.05).

Discussion
==========

We found that using both physical (EF) and chemical (TGFβ3) inducers simultaneously, leads to the best results in chondrogenesis, and specifically expression of type II collagen and SOX~9~ genes. A variety of techniques of electrical stimulation proved to be effective in therapeutic management and also in tissue culture improvement, including direct probe placement within bone tissue culture, application of changing magnetic fields, and capacitative coupling with metal plates placed outside the culture, which induce an alternating electric field within the tissue ([@R21]). In this regard, we applied just the latter of the above mentioned physical inducers in our study. We tested effects of selective and specific capacitively coupled electrical signals in enhancement of chondrogenesis in ADSCs, although, as it was mentioned earlier, these effects were fortified by using TGFβ simultaneously. It should be emphasized that it is difficult to compare our *in vitro* results with those of others, because all elements of our study, such as the source of cells, the culture method, and the features of our electric field are different from other research. Clearly, our investigation is the only study in which effects of EF on chondrogenesis are examined. However, several studies have shown the impact of EF on osteogenic differentiation *in vitro*. For example, Hronik-Tupaj *et al* ([@R22]), Hammerick *et al* ([@R23]), and also Seth D *et al* ([@R21]), were all able to differentiate stem cells into osteoblasts through EF with different features; 20 mv/cm 60 kHz frequency, 6V/cm 50 Hz, and 1V/cm 50 Hz, respectively. In *in vitro* MSCs chondrogenesis, there is usually a tendency to gene expression of type I and X collagens, therefore, fibrocartilage, and terminal hypertrophy (initiation of ossification) result respectively ([@R24]). Researchers have been investigating a technique in which they can get rid of these two unwanted collagens. Our results clearly meet this serious need. Here, electric field not only promoted chondrogenesis, but also inhibited the expression of type I and X collagens, significantly. Although, the knowledge about the mechanism of electrical stimulation on cell differentiation is still unknown, in some studies some mechanisms are raised to a clearer horizon. For example, it is demonstrated that the capacitively coupled electric stimulation of cultured bone cells causes an increase in cytosolic Ca^2+^ via voltage-gated calcium channels leading to activated calmodulin and an increase in TGFβ mRNA ([@R25]--[@R27]). We doubt whether the same mechanism(s) is operating in ADSCs.

Conclusion
==========

The coupled-capacity electric field was found as a proper effective inducer in chondrogenic differentiation of human ADSCs micromass cultures. Future studies may work on accessing significant chondrogenesis with just EF stimulator, as a safe, easy, and cheap inducer.
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###### 

Gene sequence of primers

  Gene             Primer sequences
  ---------------- ------------------------
  Collagen II-F    CTGGTGATGATGGTGAAG
  Collagen II -R   CCTGGATAACCTCTGTGA
  Sox~9~ -F        TTCAGCAGCCAATAAGTG
  Sox~9~ -R        TTCAGCAGCCAATAAGTG
  Collagen x -F    AGAATCCATCTGAGAATATGC
  Collagen x - R   CCTCTTACTGCTATACCTTTAC
  GAPDH-F          AAGCTCATTTCCTGGTATG
  GAPDH-R          CTTCCTCTTGTGCTCTTG
  Collagen I-F     CCTCCAGGGCTCCAACGAG
  Collagen I -R    TCAATCACTGTCTTGCCCCA
